{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T17:44:13Z","timestamp":1776793453702,"version":"3.51.2"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.4158\/ep09221.or","type":"journal-article","created":{"date-parts":[[2009,8,24]],"date-time":"2009-08-24T21:18:12Z","timestamp":1251148692000},"page":"42-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Giant Prolactinoma and Effectiveness of Medical Management"],"prefix":"10.1016","volume":"16","author":[{"given":"Shrikrishna V.","family":"Acharya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raju A.","family":"Gopal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Padma S.","family":"Menon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tushar R.","family":"Bandgar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nalini S.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP09221.OR_bb0010","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/S0140-6736(98)03356-X","article-title":"Growth-hormone and prolactin excess","volume":"352","author":"Colao","year":"1998","journal-title":"Lancet."},{"key":"10.4158\/EP09221.OR_bb0015","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3171\/jns.2002.97.2.0299","article-title":"Giant prolactinomas: Clinical management and long-term follow up","volume":"97","author":"Shrivastava","year":"2002","journal-title":"J Neurosurg"},{"key":"10.4158\/EP09221.OR_bb0020","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1046\/j.1365-2265.2003.01770.x","article-title":"Giant prolactinomas in men: Efficacy of cabergoline treatment","volume":"58","author":"Corsello","year":"2003","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.4158\/EP09221.OR_bb0025","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1210\/jcem-60-4-698","article-title":"Bromocriptine as primary therapy for prolactin-secreting macroadenomas: Results of a prospective multicenter study","volume":"60","author":"Molitch","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP09221.OR_bb0030","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1210\/edrv-13-2-220","article-title":"Dopamine agonists and pituitary tumor shrinkage","volume":"13","author":"Bevan","year":"1992","journal-title":"Endocr Rev."},{"key":"10.4158\/EP09221.OR_bb0035","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1056\/NEJM198309223091205","article-title":"Pergolide for the treatment of pituitary tumors secreting prolactin or growth hormone","volume":"309","author":"Kleinberg","year":"1983","journal-title":"N Engl J Med."},{"key":"10.4158\/EP09221.OR_bb0040","doi-asserted-by":"crossref","first-page":"668","DOI":"10.7326\/0003-4819-112-9-668","article-title":"Treatment of prolactin-secreting pituitary macroadenomas with the long-acting non-ergot dopamine agonist","volume":"112","author":"Vance","year":"1990","journal-title":"Ann Intern Med."},{"key":"10.4158\/EP09221.OR_bb0045","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJM199410063311403","article-title":"A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group","volume":"331","author":"Webster","year":"1994","journal-title":"N Engl J Med."},{"key":"10.4158\/EP09221.OR_bb0050","first-page":"2338","article-title":"Treatment of prolactin-secreting macroadenomas with the once-weekly dopamine agonist cabergoline","volume":"81","author":"Biller","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP09221.OR_bb0055","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1210\/jcem.82.11.4368","article-title":"Long-term and low-dose treatment with cabergoline induces macroprolactinoma shrinkage","volume":"82","author":"Colao","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP09221.OR_bb0060","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1210\/jcem.84.7.5810","article-title":"Cabergoline in the treatment of hyperprolactinemia: A study in 455 patients","volume":"84","author":"Verhelst","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP09221.OR_bb0065","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1210\/er.2005-9998","article-title":"Advances in the treatment of prolactinomas","volume":"27","author":"Gillam","year":"2006","journal-title":"Endocr Rev."},{"key":"10.4158\/EP09221.OR_bb0070","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1023\/A:1026225625897","article-title":"Dopamine resistance of prolactinomas","volume":"6","author":"Molitch","year":"2003","journal-title":"Pituitary."},{"key":"10.4158\/EP09221.OR_bb0075","first-page":"227","article-title":"Giant invasive prolactinoma: A case report and review of nine further cases","volume":"74","author":"Davis","year":"1990","journal-title":"Q J Med."},{"key":"10.4158\/EP09221.OR_bb0080","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1136\/jnnp.42.11.973","article-title":"Surgical treatment of giant pituitary adenomas","volume":"42","author":"Symon","year":"1979","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.4158\/EP09221.OR_bb0085","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF01815445","article-title":"Giant pituitary adenomas","volume":"8","author":"Pia","year":"1985","journal-title":"Neurosurg Rev."},{"key":"10.4158\/EP09221.OR_bb0090","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1507\/endocrj.45.529","article-title":"Surgical indication after bromocriptine therapy on giant prolactinomas: Effects and limitations of the medical treatment","volume":"45","author":"Saeki","year":"1998","journal-title":"Endocr J."},{"key":"10.4158\/EP09221.OR_bb0095","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0090-3019(01)00697-8","article-title":"Giant prolactinomas presenting as skull base tumors","volume":"57","author":"Minniti","year":"2002","journal-title":"Surg Neurol"},{"key":"10.4158\/EP09221.OR_bb0100","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1530\/EJE-06-0646","article-title":"Effectiveness of long-term cabergoline treatment for giant prolactinoma: Study of 12 men","volume":"156","author":"Shimon","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP09221.OR_bb0105","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000182494","article-title":"D2 dopaminergic receptors: Normal and abnormal transduction mechanisms","volume":"38","author":"Caccavelli","year":"1992","journal-title":"Horm Res."},{"key":"10.4158\/EP09221.OR_bb0110","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.1365-2265.2000.00901.x","article-title":"CSF rhinorrhoea following treatment with dopamine agonists for massive invasive prolactinomas","volume":"52","author":"Leong","year":"2002","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.4158\/EP09221.OR_bb0115","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1600-0404.2005.00514.x","article-title":"Efficacy and safety of high-dose cabergoline in Parkinson's disease","volume":"113","author":"Odin","year":"2006","journal-title":"Acta Neurol Scand"},{"key":"10.4158\/EP09221.OR_bb0120","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1210\/jc.2007-1403","article-title":"Increased prevalence of tricuspid regurgitation in patients with prolactinomas chronically treated with cabergoline","volume":"93","author":"Colao","year":"2008","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20403593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20403593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/J338L735201P4714.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:50:43Z","timestamp":1761515443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20403593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S1530891X20403593"],"URL":"https:\/\/doi.org\/10.4158\/ep09221.or","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Giant Prolactinoma and Effectiveness of Medical Management","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP09221.OR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}